199.920
199.92 (0%)
As of Jun 15, 2023
Prometheus Biosciences, Inc. [RXDX]
Source:
Company Overview
Prometheus Biosciences, Inc is a clinical-stage biotechnology company pioneering a precision medicine approach to the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment of immune-mediated diseases, starting first with inflammatory bowel disease (IBD).
Country | United States |
Headquarters | san diego, california |
Phone Number | (858) 422-4300 |
Industry | manufacturing |
CEO | Mark C. Mckenna |
Website | prometheusbiosciences.com |